BSI response to study on AstraZeneca/Oxford vaccine and rare bleeding disorder
BSI response to study on AstraZeneca/Oxford vaccine and rare autoimmune bleeding disorder known as idiopathic thrombocytopenic purpura (ITP).
Championing your public engagement ventures
Our Public Engagement Manager, Erika Aquino, explains the different ways the BSI is here to guide and support our members with their public engagement endeavours.
BSI membership survey – the results
We report on the responses to our recent membership survey, which aimed to gain insight into our work and the effects of the pandemic ahead of our new strategic plan.
BSI Forum: here to represent you
Find out about our discussions during the last Forum meeting and hear Dr Laura Pallett share her experience as an Early Career Representative.
Many patients with COVID-19 produce immune responses against their body’s own tissues or organs
A new study has found that many patients with COVID-19 produce immune responses against their body’s own tissues or organs. The paper was published in Clinical & Experimental Immunology.
9th Annual Meeting of the International Cytokine & Interferon Society
The ICIS is the world’s largest multidisciplinary organization advancing both fundamental and clinical research specific to the role of cytokines in health and disease. Their 9th Annual Meeting, 'Celtic cytokines sensing and interpreting cytokine & interferon cues', will be a hybrid event combining the physical event at the Cardiff City Hall with a custom Virtual Meeting platform.
BSI response to approval of Janssen vaccine in the UK
BSI response to approval of the Janssen COVID-19 vaccine by the MHRA for use in the UK.
BSI response to new APPG on Vaccinations For All report on improving vaccine uptake
British Society for Immunology response to new repot from the All Party Parliamentary Group (APPG) on Vaccinations For All looking into the factors that improve or hinder vaccine uptake.
Vaccine engagement starts...as part of a BSI Regional Group
BSI member, Dr Brian Ferguson shares his thoughts on increasing the public's understanding of COVID-19 vaccines in this case study for our new 'Vaccine engagement starts...' series.
ESID 2021 Online Symposium
The Clinical Working Party of the European Society of Immunodeficiencies Multidisciplinary Symposium on the Immunological Consequences of Targeted Immune Therapies (ESID 2021) is a unique symposium bringing together professionals from different fields to share their expertise in the treatment and management of acquired immunodeficiencies.